Innovent Doses First Patient in Phase 3 Trial of Mazdutide for Obstructive Sleep Apnea and Obesity in China

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

June 16, 2025 | Monday | News
Sinovac’s Showdown: Board Fights Back Against Dissident Slate as $55/Share Dividend Hangs in Balance

Sinovac Biotech Ltd. (NASDAQ: SVA), a prominent player in China's biopharmaceutical sector, has entered a defining phase in its corporate history. As the...

June 13, 2025 | Friday | Reports
Kelun-Biotech’s TROP2 ADC-Immunotherapy Combo Granted Breakthrough Therapy Designation in China for First-Line NSCLC

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumo...

June 11, 2025 | Wednesday | News
Sanofi Begins Early Q3 Shipments of Beyfortus to Meet Growing Demand for RSV Protection in Infants

Sanofi is shipping Beyfortus (nirsevimab) starting in early Q3 to ensure broad availability well ahead of the 2025-2026 respiratory syncytial virus (RSV)...

June 10, 2025 | Tuesday | News
Agenus and Zydus Forge Strategic Partnership to Advance BOT/BAL Immunotherapy and Launch BioCDMO Operations in the U.S.

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifescienc...

June 05, 2025 | Thursday | News
Biocytogen and NJCTTQ Receive NMPA IND Approval for NTB003 to Treat Thyroid Eye Disease

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJC...

June 05, 2025 | Thursday | News
Acerand Therapeutics Doses First Patient in Phase I Trial of Novel CYP11A1 Inhibitor ACE-232 for Prostate Cancer

Acerand Therapeutics, a clinical-stage biotech company focusing on the discovery and development of innovative small-molecule therapies in oncology, toda...

June 05, 2025 | Thursday | News
Astellas Inks $1.54 Billion Licensing Deal with Evopoint for ADC Candidate XNW27011 Targeting CLDN18.2

- Agreement grants Astellas exclusive worldwide rights (excluding China's mainland, Hong Kong, Macao and Taiwan region) to develop and commercialize XNW2...

May 30, 2025 | Friday | News
Mindray Unveils BeneVision V Series at Euroanaesthesia 2025, Integrating Ultrasound and Wireless Monitoring for Smarter ICU Care

 Mindray , a leading global developer of healthcare technologies, launched its BeneVision V Series patient monitoring solution at Euroanaesthes...

May 27, 2025 | Tuesday | News
Eli Lilly’s Kisunla™ (donanemab) Receives Marketing Authorization in Australia for Early Alzheimer’s Treatment

 Eli Lilly and Company  announced that the Australian Therapeutic Goods Administration (TGA) has granted marketing authorization for Kisunla (d...

May 22, 2025 | Thursday | News
Rani Therapeutics and Chugai Pharmaceutical Collaborate to Evaluate Oral Biologics Delivery via RaniPill®

Rani Therapeutics Holdings, Inc., a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs,  announced the compa...

May 21, 2025 | Wednesday | News
WuXi Biologics and CANbridge Launch China’s First Locally Developed Enzyme Replacement Therapy for Gaucher Disease

Enabled by WuXi Biologics' industry-leading integrated technology platform, velaglucerase-beta for injection has successfully advanced from concept to ...

May 19, 2025 | Monday | News
Shanghai Ark Biopharma Reports Positive Phase II Results for AK3280 in IPF Patients Signaling New Hope in Fibrotic Lung Disease Treatment

Shanghai Ark Biopharmaceutical announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of idiopathic...

May 16, 2025 | Friday | News
Xuanzhu Biopharma’s Bireociclib Approved by NMPA Marks Breakthrough in Advanced Breast Cancer Treatment in China

National Medical Products Administration attracted widespread attention in the oncology community and the pharmaceutical market. Bireociclib tablets (tra...

May 16, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close